Better realization drives healthcare performance

Company
11 Mar 2024
5 Min read 
  • Apollo Hospitals delivered better-than-expected performance for 3QFY24.
  •  Growth in ARPOB/in-patient volume and EBITDA break-even in Healthco led to superior profitability.
  •  Earnings estimate raised for FY25/FY26 due to faster turnaround of Apollo 24/7 business and other initiatives.
  •  Price target set at INR7,400 with a BUY rating on the stock.
  •  Efforts underway to improve occupancy rates and add 2K beds over the next three years.
  •  Revenue/EBITDA CAGR expected to be 15%/23% over FY24-26.
Login / Open Demat Account to read the report

Never Miss Out on Hot Market Updates

Get exclusive market news delivered to your inbox - on priority

Click here to see your activities